M. Spiteri (Stoke on Trent, UK), E. Brambilla (Grenoble, France)
Differences of the hypoxia driven gene response in small (H69) and nonsmall (H23) cell lung carcinomas
F. Rose, P. Mahlik, B. Reichmann, D. Giannakakis, R. Vosswinkel, J. Appel, S. Krick, R. Schermuly, F. Grimminger, W. Seeger, J. Hanze (Giessen, Germany)
|  |
Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells
D. Giannakakis, F. Rose, B. Reichmann, P. Mahlik, J. Appel, S. Krick, F. Grimminger, W. Seeger, J. Hanze (Giessen, Germany)
| |
Non-random chromosomal breakpoints and genetic predisposition to nonsmall cell lung cancer
U. Egeli, B. Tunca, C. Gebitekin, G. Cecener (Bursa, Turkey)
| |
Down-regulation of retinoid receptors in malignant mesotheliomas
J. Moldvay, Y. Grignon, J. M. Vignaud, C. Rochette-Egly, Y. Martinet, N. Martinet (Nancy, Strasbourg, France)
| |
Radiation/cisplatin/vinorelbine therapy increase p53 protein phosphorylated at serine 392 in recurrent primary squamous cell lung cancer
R. M. Mroz, A. Holownia, M. Kozlowski, E. Chyczewska, J. Laudanski, L. Chyczewski, J. J. Braszko (Bialystok, Poland)
| |
Flow cytometric DNA ploidy analysis of the lung cancer during chemotherapy
R. M. Mroz, E. Chyczewska, A. Holownia, T. Izycki, L. Chyczewski, J. J. Braszko (Bialystok, Poland)
| |